137 related articles for article (PubMed ID: 37768120)
21. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw W; Yan TD; Barrios P; Gómez Portilla A; de Hingh IH; Ceelen WP; Pelz JO; Piso P; González-Moreno S; Van Der Speeten K; Morris DL
J Clin Oncol; 2012 Jul; 30(20):2449-56. PubMed ID: 22614976
[TBL] [Abstract][Full Text] [Related]
22. Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.
Scally CP; Fournier KF; Mansfield PF
JAMA Surg; 2021 Mar; 156(3):e206364. PubMed ID: 33502464
[No Abstract] [Full Text] [Related]
23. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.'.
Marano L; Marrelli D; Sammartino P; Biacchi D; Graziosi L; Marino E; Coccolini F; Fugazzola P; Valle M; Federici O; Baratti D; Deraco M; Di Giorgio A; Macrì A; Pasqual EM; Framarini M; Vaira M; Roviello F;
Ann Surg Oncol; 2021 Dec; 28(13):9060-9070. PubMed ID: 34057569
[TBL] [Abstract][Full Text] [Related]
24. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures.
Passot G; Vaudoyer D; Villeneuve L; Kepenekian V; Beaujard AC; Bakrin N; Cotte E; Gilly FN; Glehen O
J Surg Oncol; 2016 Jun; 113(7):796-803. PubMed ID: 27110915
[TBL] [Abstract][Full Text] [Related]
25. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
Quénet F; Elias D; Roca L; Goéré D; Ghouti L; Pocard M; Facy O; Arvieux C; Lorimier G; Pezet D; Marchal F; Loi V; Meeus P; Juzyna B; de Forges H; Paineau J; Glehen O;
Lancet Oncol; 2021 Feb; 22(2):256-266. PubMed ID: 33476595
[TBL] [Abstract][Full Text] [Related]
26. Peritoneal carcinomatosis index and overall survival in patients taken to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
López-Basave HN; Morales-Vázquez F; Herrera-Gómez Á; Miranda-Devora G; Padilla-Rosciano AE; Castillo-Morales C; Paleta-Torres CA; Vázquez-Cortes E
Cir Cir; 2023; 91(2):195-199. PubMed ID: 37084306
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of non-primary origin.
Carboni F; Federici O; Zazza S; Corona F; Massimi F; Sperduti I; Valle M
Langenbecks Arch Surg; 2021 Dec; 406(8):2817-2825. PubMed ID: 34686891
[TBL] [Abstract][Full Text] [Related]
28. Role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
López-Basave HN; Quiroz-Sandoval OA; Padilla-Rosciano AE; León-Takahashi AM; Miranda-Devora G; Arrollo-Monroy A
Cir Cir; 2018; 86(3):277-284. PubMed ID: 29950734
[TBL] [Abstract][Full Text] [Related]
29. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis: Our Initial Experience.
Bartoş A; Bartoş D; Raluca S; Mitre C; Hadade A; Iancu I; Cioltean C; Iancu C; Militaru C; Părău A; Breazu C
Chirurgia (Bucur); 2019; 114(2):222-233. PubMed ID: 31060655
[No Abstract] [Full Text] [Related]
30. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for a limited low-grade pseudomyxoma peritonei-a video vignette.
Arjona-Sánchez Á; Durán M; Rodríguez-Ortiz L; Rufián-Peña S; Briceño J
Colorectal Dis; 2021 Jan; 23(1):331-332. PubMed ID: 33070418
[No Abstract] [Full Text] [Related]
31. [Effects of laparoscopic hyperthermic intraperitoneal perfusion chemotherapy combined with intraperitoneal and systemic chemotherapy treatment in patients with untreated gastric cancer with peritoneal metastasis].
Li S; Xue K; Dai HM; Wang YK; Shan F; Li ZY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):442-447. PubMed ID: 37217352
[No Abstract] [Full Text] [Related]
32. A proposal of Brazilian Society of Surgical Oncology (BSSO/SBCO) for standardizing cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma.
Batista TP; Sarmento BJQ; Loureiro JF; Petruzziello A; Lopes A; Santos CC; Quadros CA; Akaishi EH; Cordeiro EZ; Coimbra FJF; Laporte GA; Castro LS; Batista RMSS; Aguiar S; Costa WL; Ferreira FO;
Rev Col Bras Cir; 2017; 44(5):530-544. PubMed ID: 29019584
[TBL] [Abstract][Full Text] [Related]
33. Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial.
Koemans WJ; van der Kaaij RT; Wassenaar ECE; Boerma D; Boot H; Sikorska K; Los M; Grootscholten C; Hartemink KJ; Veenhof AAFA; Kodach L; Snaebjornsson P; van Sandick JW
J Surg Oncol; 2021 Mar; 123(4):904-910. PubMed ID: 33428786
[TBL] [Abstract][Full Text] [Related]
34. Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Mehta A; Mittal R; Chandrakumaran K; Carr N; Dayal S; Mohamed F; Moran B; Cecil T
Dis Colon Rectum; 2017 Nov; 60(11):1155-1161. PubMed ID: 28991079
[TBL] [Abstract][Full Text] [Related]
35. Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma.
Lemoine L; Sugarbaker P; Van der Speeten K
Int J Hyperthermia; 2017 Aug; 33(5):582-592. PubMed ID: 28540826
[TBL] [Abstract][Full Text] [Related]
36. The importance of primary tumor origin in gastrointestinal malignancies undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Leigh N; Solomon D; Pletcher E; Labow DM; Magge DR; Sarpel U; Golas BJ
World J Surg Oncol; 2020 Jul; 18(1):182. PubMed ID: 32703239
[TBL] [Abstract][Full Text] [Related]
37. [Management of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Balaphas A; Belfontali V; Ris F; Lanitis A; Meier RP; Amram ML; Roth A; Huber O; Berney T; Morel P
Rev Med Suisse; 2016 Jun; 12(523):1190-4. PubMed ID: 27487625
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies.
Cascales Campos PA; González-Gil A; Gómez-Ruiz AJ; Gil-Gómez E; Alconchel-Gago F; Navarro-Barrios A; Martínez-García J; Alonso-Romero JL; Nieto A; Barceló-Valcarcel F; Gil-Martínez J
Hernia; 2020 Apr; 24(2):257-263. PubMed ID: 31069579
[TBL] [Abstract][Full Text] [Related]
39. Mode of Presentation in 1070 Patients With Perforated Epithelial Appendiceal Tumors, Predominantly with Pseudomyxoma Peritonei.
Shariff US; Chandrakumaran K; Dayal S; Mohamed F; Cecil TD; Moran BJ
Dis Colon Rectum; 2020 Sep; 63(9):1257-1264. PubMed ID: 33216496
[TBL] [Abstract][Full Text] [Related]
40. Surgical treatment of peritoneal carcinomatosis: current treatment modalities.
Kulu Y; Müller-Stich B; Büchler MW; Ulrich A
Langenbecks Arch Surg; 2014 Jan; 399(1):41-53. PubMed ID: 24249036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]